In late July, months after news of the Zika outbreak in South America started to make headlines in the U.S., the first locally acquired Zika cases in the continental United States were confirmed in Miami-Dade County. By August 31, the Centers for Disease Control (CDC) had confirmed 35 cases of locally-acquired Zika in Florida.
With the health and economic well-being of the region suddenly at risk, the Miami-Dade County Mosquito Control program was abruptly thrust into the spotlight. Not only were its citizens calling for the most effective container-mosquito control interventions available, the eyes of the nation were trained on Miami-Dade to see how it would respond and how effective that response would be.
Like other programs in Florida, the majority of Miami-Dade County’s mosquito control program was based on insecticides that target adult mosquitoes (adulticides). Since adult mosquitoes transmit disease, the rationale for treating primarily with adulticide is not uncommon. But the pressing health crisis in Miami prompted officials to add new applications of biological larvicides which target immature mosquitoes Building on new application technology and promising results seen in neighboring districts, Miami-Dade control officials expanded the breadth of its Integrated Vector Management (IVM) program by scheduling wide area sprays of bacterial larvicides through September.